| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |